The following data is part of a premarket notification filed by Fujirebio Diagnostics, Inc. with the FDA for Architect Sirolimus Assay.
Device ID | K070822 |
510k Number | K070822 |
Device Name: | ARCHITECT SIROLIMUS ASSAY |
Classification | Sirolimus Test System |
Applicant | FUJIREBIO DIAGNOSTICS, INC. 201 GREAT VALLEY PARKWAY Malvern, PA 19355 -1308 |
Contact | Diana Lyn Dickson |
Correspondent | Diana Lyn Dickson FUJIREBIO DIAGNOSTICS, INC. 201 GREAT VALLEY PARKWAY Malvern, PA 19355 -1308 |
Product Code | NRP |
CFR Regulation Number | 862.3840 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2007-03-26 |
Decision Date | 2007-09-28 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00380740001353 | K070822 | 000 |
00380740001346 | K070822 | 000 |
00380740001339 | K070822 | 000 |
00380740154233 | K070822 | 000 |
00380740150990 | K070822 | 000 |